Copyright
©The Author(s) 2015.
World J Pharmacol. Jun 9, 2015; 4(2): 193-209
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.193
Published online Jun 9, 2015. doi: 10.5497/wjp.v4.i2.193
Table 3 Common used drug classes which require dose adjustment with chronic kidney disease
Drug class | Adjust dose in CKD stage 1-3 | Avoid in CKD stages 4 and 5 |
ACE-inhibitors and Angiotensin 2 receptor blockers | All ACE inhibitors | Olmesartan |
Diuretics | Potassium-sparing and thiazide diuretics | Potassium-sparing and thiazide diuretics |
Beta-blockers | Acebutolol, atenolol, bisoprolol, nadolol, sotalol | Sotalol |
Lipid lowering agents | Pravastatin, rosuvastatin, fibrates | Glyburide, metformin, exanitide |
Hypoglycaemic agents | Gliclazide, acarbose, insulin, gliptins | |
Analgesia (NSAIDs and opioids) | Codeine, tramadol, morphine, oxycodone, | All NSAIDs, pethidine |
Psychotropic agents | Lithium, gabapentin, pregabalin, topiramate, vigabatrin, bupropion, duloxetine, paroxetine, venlafaxine | |
Miscellaneous | Allopurinol, colchicine, digoxin | Dabigatran Rivaroxaban (CI stage 5, dose adjust in stage 4 CKD) Apixaban (CI stage 5, dose adjust in stage 4) |
- Citation: Lavan AH, O’Grady J, Gallagher PF. Appropriate prescribing in the elderly: Current perspectives. World J Pharmacol 2015; 4(2): 193-209
- URL: https://www.wjgnet.com/2220-3192/full/v4/i2/193.htm
- DOI: https://dx.doi.org/10.5497/wjp.v4.i2.193